RARRES2 and neoplasm: Ectopic expression of chemokines/chemoattractants known to preferentially attract effector lymphocytes, including CXCR3 ligands as well as CX3CL1 and chemerin, was shown to positively affect the antitumor nature of tumor-infiltrating lymphocytes with a large proportion of NK cells (88–91).